Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Asha Spandana K M"'
Autor:
Asha Spandana K M, Mohit Angolkar, Mohamed Rahamathulla, Kamal Y. Thajudeen, Mohammed Muqtader Ahmed, Syeda Ayesha Farhana, Thippeswamy Boreddy Shivanandappa, Sharanya Paramshetti, Riyaz Ali M. Osmani, Jawahar Natarajan
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 720 (2024)
Bromocriptine (BCR) presents poor bioavailability when administered orally because of its low solubility and prolonged first-pass metabolism. This poses a significant challenge in its utilization as an effective treatment for managing Parkinson’s d
Externí odkaz:
https://doaj.org/article/cc8e72ea24264222a6b0b1fdd3cc1028
Autor:
SUSHMITA SANKESHWARI, GANGADHARAPPA H. V., ASHA SPANDANA K. M., ANU ELIYAS, SHAILESH THIRUMALESHWAR, PYDA VENKATA HARSHA VARDHAN
Publikováno v:
International Journal of Applied Pharmaceutics. :12-27
Designing an appropriate dosage form in medical treatment for the pediatric population is very challenging. The major challenges faced during designing the oral solid dosage form for pediatrics are also the prerequisites for the development of the do
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:3667-3674
The insulin discovery during the past century is considered as the major breakout in the health sector. It is considered as lifesaving medication for T1DM and T2DM. In the advancement of peptide chemistry, pharmacology, cell signalling and structural
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:3626-3636
Cancer is treated effectively by means of currently available medical knowledge and equipment for therapy. Still, earlier diagnosis of cancer is a crucial factor to determine the probabilities of a cancer patient for survival. Cancer must be identifi
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:2410-2423
Parkinson's disease (PD) is a neurodegenerative disorder associated with dopaminergic neuron degeneration and/or loss of neuronal activity. Current idiopathic PD treatments focus primarily on the use of pharmacological agents to improve PD patients '
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:1130-1135
Lipid Nanoparticles have gained increased attention during the last few decades. These carrier systems offer many advantages over conventional drug delivery system, including protection of the entrapped active ingredient from environmental (pH) or ph